Clinical Trial Update: Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients with Mild to Moderately Active Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial is evaluating the efficacy and safety of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) in patients with mild to moderatel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CICR-NAM (Nicotinamide) (nicotinamide)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Ulcerative Colitis, Unspecified | Phase 2, Phase 3 | Status: RECRUITING